Evidence map›Paper›PMID 29100015›Full record

ArticleCell stem cell2017

An endosiRNA-Based Repression Mechanism Counteracts Transposon Activation during Global DNA Demethylation in Embryonic Stem Cells.

Rebecca V Berrens, Simon Andrews, Dominik Spensberger, Fátima Santos, Wendy Dean, Poppy Gould, Jafar Sharif, Nelly Olova, Tamir Chandra, Haruhiko Koseki and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Cell stem cell, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
16.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. PSMC3 promotes RNAi by maintaining AGO2 stability through USP14.Cellular & molecular biology letters · 2022
    Article
  19. Transposon control as a checkpoint for tissue regeneration.Development (Cambridge, England) · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Rebecca V BerrensEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, UK; University of Cambridge, The Old Schools, Trinity Lane, Cambridge CB2 1TN, UK. Electronic address: rebecca.berrens@gmail.com.
Simon AndrewsEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, UK.
Dominik SpensbergerEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, UK.
Fátima SantosEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, UK; University of Cambridge, The Old Schools, Trinity Lane, Cambridge CB2 1TN, UK.
Wendy DeanEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, UK.
Poppy GouldEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, UK.
Jafar SharifRIKEN Research Center for Allergy and Immunology, 1-7-22 Suehiro-cho, Tsurumi, Yokohama, 230-0045 Kanagawa, Japan.
Nelly OlovaEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, UK.
Tamir ChandraEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, UK.
Haruhiko KosekiRIKEN Research Center for Allergy and Immunology, 1-7-22 Suehiro-cho, Tsurumi, Yokohama, 230-0045 Kanagawa, Japan.
Ferdinand von MeyennEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, UK. Electronic address: vonmeyenn@babraham.ac.uk.
Wolf ReikEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, UK; University of Cambridge, The Old Schools, Trinity Lane, Cambridge CB2 1TN, UK; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. Electronic address: wolf.reik@babraham.ac.uk.
Babraham Institute · GBRIKEN Center for Integrative Medical Sciences · JPWellcome Sanger Institute · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

Erasure of DNA methylation and repressive chromatin marks in the mammalian germline leads to risk of transcriptional activation of transposable elements (TEs). Here, we used mouse embryonic stem cells (ESCs) to identify an endosiRNA-based mechanism involved in suppression of TE transcription. In ESCs with DNA demethylation induced by acute deletion of Dnmt1, we saw an increase in sense transcription at TEs, resulting in an abundance of sense/antisense transcripts leading to high levels of ARGONAUTE2 (AGO2)-bound small RNAs. Inhibition of Dicer or Ago2 expression revealed that small RNAs are involved in an immediate response to demethylation-induced transposon activation, while the deposition of repressive histone marks follows as a chronic response. In vivo, we also found TE-specific endosiRNAs present during primordial germ cell development. Our results suggest that antisense TE transcription is a "trap" that elicits an endosiRNA response to restrain acute transposon activity during epigenetic reprogramming in the mammalian germline.

Indexed as

DNA DemethylationAnimalsArgonaute ProteinsDNA (Cytosine-5-)-Methyltransferase 1DNA Transposable ElementsEmbryonic Stem CellsFemaleGene DeletionGene Knockdown TechniquesHistone CodeHistonesMaleMiceRNA InterferenceRNA, Small InterferingTranscription, GeneticAgo2 protein, mouseArgonaute ProteinsDNA (Cytosine-5-)-Methyltransferase 1DNA Transposable ElementsHistonesRNA, Small InterferingDNMT1endogenous retrovirusesgerm lineIAP elementsprimordial germ cellrepeatsRNAismall RNAstransposable element

Identifiers

PMID29100015
PMCPMC5678422
OpenAlexW2765513097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.